SCHEMBL31723920

N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	NPY4R	P50391	9/20	0.45

▸	NPY1R	P25929	6/20	0.45

▸	NPY2R	P49146	4/20	0.45

▸	NPY5R	Q15761	4/20	0.45

▸	FNTA	P49354	11/20	0.44

▸	FNTB	P49356	11/20	0.44

▸	PGGT1B	P53609	10/20	0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30438178	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL31723816	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL30579938	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL31723891	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL31723802	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL31723893	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL31723826	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL31723855	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL31391097	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA
SCHEMBL29840653	1.00	NPY4R (0.45)	NPY4RNPY1RNPY2RNPY5RFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20250345410-A1	VACCINATION IN NEWBORNS AND INFANTS	CureVac SE (DE)	2025-11-13	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20250345410-A1	VACCINATION IN NEWBORNS AND INFANTS	HLA-DRB1, TLR3, TLR9	NPY4R 2247/4885NPY1R 2188/4885NPY2R 2305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.